Annual EBITDA:
$473.73M+$127.14M(+36.68%)Summary
- As of today, GMED annual EBITDA is $473.73 million, with the most recent change of +$127.14 million (+36.68%) on December 31, 2024.
- During the last 3 years, GMED annual EBITDA has risen by +$209.00 million (+78.95%).
- GMED annual EBITDA is now at all-time high.
Performance
GMED EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$205.81M+$8.95M(+4.55%)Summary
- As of today, GMED quarterly EBITDA is $205.81 million, with the most recent change of +$8.95 million (+4.55%) on September 30, 2025.
- Over the past year, GMED quarterly EBITDA has increased by +$89.87 million (+77.51%).
- GMED quarterly EBITDA is now at all-time high.
Performance
GMED Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$724.86M+$89.87M(+14.15%)Summary
- As of today, GMED TTM EBITDA is $724.86 million, with the most recent change of +$89.87 million (+14.15%) on September 30, 2025.
- Over the past year, GMED TTM EBITDA has increased by +$286.70 million (+65.43%).
- GMED TTM EBITDA is now at all-time high.
Performance
GMED TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
GMED EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +36.7% | +77.5% | +65.4% |
| 3Y3 Years | +79.0% | +168.6% | +139.2% |
| 5Y5 Years | +106.4% | +204.6% | +279.0% |
GMED EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +79.0% | at high | +171.3% | at high | +139.2% |
| 5Y | 5-Year | at high | +165.6% | at high | +214.0% | at high | +279.0% |
| All-Time | All-Time | at high | +386.9% | at high | +1350.3% | at high | +2570.1% |
GMED EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $205.81M(+4.5%) | $724.86M(+14.2%) |
| Jun 2025 | - | $196.86M(+19.8%) | $634.99M(+12.2%) |
| Mar 2025 | - | $164.29M(+4.0%) | $565.84M(+13.4%) |
| Dec 2024 | $473.73M(+36.7%) | $157.90M(+36.2%) | $498.94M(+13.9%) |
| Sep 2024 | - | $115.94M(-9.2%) | $438.16M(+7.2%) |
| Jun 2024 | - | $127.71M(+31.1%) | $408.56M(+10.2%) |
| Mar 2024 | - | $97.39M(+0.3%) | $370.84M(+6.2%) |
| Dec 2023 | $346.58M(+13.8%) | $97.12M(+12.5%) | $349.32M(+5.5%) |
| Sep 2023 | - | $86.34M(-4.1%) | $331.09M(+3.0%) |
| Jun 2023 | - | $89.99M(+18.6%) | $321.37M(+2.0%) |
| Mar 2023 | - | $75.87M(-3.8%) | $314.98M(+3.4%) |
| Dec 2022 | $304.50M(+15.0%) | $78.88M(+2.9%) | $304.65M(+0.5%) |
| Sep 2022 | - | $76.63M(-8.3%) | $303.00M(+1.9%) |
| Jun 2022 | - | $83.60M(+27.5%) | $297.42M(+1.6%) |
| Mar 2022 | - | $65.55M(-15.1%) | $292.70M(-2.1%) |
| Dec 2021 | $264.73M(+48.4%) | $77.23M(+8.7%) | $299.04M(-0.1%) |
| Sep 2021 | - | $71.05M(-9.9%) | $299.22M(+1.2%) |
| Jun 2021 | - | $78.88M(+9.7%) | $295.75M(+28.0%) |
| Mar 2021 | - | $71.89M(-7.1%) | $231.07M(+14.0%) |
| Dec 2020 | $178.35M(-22.3%) | $77.41M(+14.6%) | $202.75M(+6.0%) |
| Sep 2020 | - | $67.58M(+376.2%) | $191.25M(+5.4%) |
| Jun 2020 | - | $14.19M(-67.4%) | $181.50M(-18.7%) |
| Mar 2020 | - | $43.56M(-33.9%) | $223.14M(-2.8%) |
| Dec 2019 | $229.49M(+5.0%) | $65.92M(+14.0%) | $229.49M(+2.0%) |
| Sep 2019 | - | $57.82M(+3.6%) | $225.02M(+4.1%) |
| Jun 2019 | - | $55.83M(+11.9%) | $216.23M(+1.5%) |
| Mar 2019 | - | $49.91M(-18.8%) | $213.08M(-2.5%) |
| Dec 2018 | $218.51M | $61.46M(+25.3%) | $218.51M(+1.8%) |
| Sep 2018 | - | $49.03M(-6.9%) | $214.55M(-0.2%) |
| Jun 2018 | - | $52.68M(-4.8%) | $214.97M(+1.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $55.35M(-3.7%) | $211.22M(+1.2%) |
| Dec 2017 | $205.39M(+6.4%) | $57.49M(+16.2%) | $208.81M(+1.9%) |
| Sep 2017 | - | $49.45M(+1.1%) | $204.86M(+1.4%) |
| Jun 2017 | - | $48.93M(-7.6%) | $202.08M(+0.5%) |
| Mar 2017 | - | $52.94M(-1.1%) | $201.15M(+1.7%) |
| Dec 2016 | $192.99M(-1.3%) | $53.54M(+14.7%) | $197.74M(+1.4%) |
| Sep 2016 | - | $46.68M(-2.7%) | $194.91M(-0.1%) |
| Jun 2016 | - | $48.00M(-3.1%) | $195.03M(+2.5%) |
| Mar 2016 | - | $49.53M(-2.3%) | $190.34M(+2.9%) |
| Dec 2015 | $195.59M(+22.6%) | $50.71M(+8.4%) | $185.04M(+2.0%) |
| Sep 2015 | - | $46.79M(+8.0%) | $181.44M(+3.7%) |
| Jun 2015 | - | $43.31M(-2.1%) | $174.99M(+3.0%) |
| Mar 2015 | - | $44.23M(-6.1%) | $169.94M(+2.5%) |
| Dec 2014 | $159.59M(+32.0%) | $47.11M(+16.8%) | $165.78M(+3.4%) |
| Sep 2014 | - | $40.34M(+5.4%) | $160.35M(+3.9%) |
| Jun 2014 | - | $38.26M(-4.5%) | $154.34M(+1.8%) |
| Mar 2014 | - | $40.07M(-3.9%) | $151.54M(+4.3%) |
| Dec 2013 | $120.93M(-8.9%) | $41.68M(+21.4%) | $145.36M(+5.8%) |
| Sep 2013 | - | $34.33M(-3.2%) | $137.41M(+1.9%) |
| Jun 2013 | - | $35.46M(+4.6%) | $134.79M(+1.1%) |
| Mar 2013 | - | $33.89M(+0.5%) | $133.26M(+0.9%) |
| Dec 2012 | $132.68M(+14.6%) | $33.73M(+6.4%) | $132.12M(-23.0%) |
| Sep 2012 | - | $31.70M(-6.6%) | $171.63M(-18.8%) |
| Jun 2012 | - | $33.93M(+3.6%) | $211.39M(-13.8%) |
| Mar 2012 | - | $32.75M(-55.3%) | $245.18M(+2.3%) |
| Dec 2011 | $115.78M(+9.6%) | $73.25M(+2.5%) | $239.58M(+44.0%) |
| Sep 2011 | - | $71.45M(+5.5%) | $166.32M(+75.3%) |
| Jun 2011 | - | $67.72M(+149.5%) | $94.87M(+249.5%) |
| Mar 2011 | - | $27.15M | $27.15M |
| Dec 2010 | $105.67M(+8.6%) | - | - |
| Dec 2009 | $97.30M | - | - |
FAQ
- What is Globus Medical, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Globus Medical, Inc.?
- What is Globus Medical, Inc. annual EBITDA year-on-year change?
- What is Globus Medical, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Globus Medical, Inc.?
- What is Globus Medical, Inc. quarterly EBITDA year-on-year change?
- What is Globus Medical, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Globus Medical, Inc.?
- What is Globus Medical, Inc. TTM EBITDA year-on-year change?
What is Globus Medical, Inc. annual EBITDA?
The current annual EBITDA of GMED is $473.73M
What is the all-time high annual EBITDA for Globus Medical, Inc.?
Globus Medical, Inc. all-time high annual EBITDA is $473.73M
What is Globus Medical, Inc. annual EBITDA year-on-year change?
Over the past year, GMED annual EBITDA has changed by +$127.14M (+36.68%)
What is Globus Medical, Inc. quarterly EBITDA?
The current quarterly EBITDA of GMED is $205.81M
What is the all-time high quarterly EBITDA for Globus Medical, Inc.?
Globus Medical, Inc. all-time high quarterly EBITDA is $205.81M
What is Globus Medical, Inc. quarterly EBITDA year-on-year change?
Over the past year, GMED quarterly EBITDA has changed by +$89.87M (+77.51%)
What is Globus Medical, Inc. TTM EBITDA?
The current TTM EBITDA of GMED is $724.86M
What is the all-time high TTM EBITDA for Globus Medical, Inc.?
Globus Medical, Inc. all-time high TTM EBITDA is $724.86M
What is Globus Medical, Inc. TTM EBITDA year-on-year change?
Over the past year, GMED TTM EBITDA has changed by +$286.70M (+65.43%)